AVALO THERAPEUTICS INC (AVTX) Stock Income Statement
NASDAQ:AVTX • US05338F3064
Current stock price
13.92 USD
-0.83 (-5.63%)
At close:
13.92 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 59.00K | 441.00K | 1.92M | 18.05M | 5.40M | |||
| Cost Of Goods | 0.00 | -366.00K | 1.28M | 3.43M | 1.49M | |||
| Gross Profit | 59.00K | 807.00K | 640.00K | 14.62M | 3.91M | |||
| Operating Expenses | 72.98M | 41.68M | 24.08M | 52.06M | 86.04M | |||
| Research and Development | 50.08M | 24.44M | 13.78M | 31.31M | 59.84M | |||
| Selling, General, and Administrative Expenses | 22.90M | 17.24M | 10.30M | 20.71M | 24.66M | |||
| Operating Income | -72.92M | -40.87M | -23.44M | -37.44M | -82.13M | |||
| Interest Income/Expense | -5.17M | 387.00K | -4.14M | -4.17M | -2.39M | |||
| Other Income/Expense | 0.00 | 33.11M | -42.00K | -20.00K | -20.00K | |||
| Non Recurring Items | 0.00 | -27.64M | -3.91M | N/A | 0.00 | |||
| Income Before Taxes | -78.09M | -35.02M | -31.53M | -41.63M | -84.55M | |||
| Income Tax | 165.00K | 114.00K | 14.00K | 30.00K | -200.00K | |||
| Net Income | -78.26M | -35.13M | -31.54M | -41.66M | -84.38M | |||
| EBITDA | -72.58M | -40.70M | -23.29M | -37.27M | -80.47M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.84 | -7.94 | -113.58 | -4.43 | -10.13 | |||
| Non GAAP EPS | -6.49 | -164.27 | -488.22 | -1.08K | -2.39K | |||
| Statistics | ||||||||
| Gross Profit Margin | 100.00% | 182.99% | 33.26% | 81.00% | 72.41% | |||
| Profit Margin | -132642.37% | -7965.76% | -1639.50% | -230.80% | -1562.59% | |||
| Operating Profit Margin | -123601.69% | -9267.80% | -1218.50% | -207.42% | -1520.93% | |||
All data in USD